- Pan Global Resources (PGZ) released results from preliminary test work at its La Romana copper-tin-silver discovery in Spain
- The results achieved for the first phase of testing demonstrate the potential for a conventional flotation process flowsheet capable of recovering copper into a saleable concentrate
- The favourable combination of low deleterious metals and coarse primary grind size and potential for lower final energy consumption, is highly encouraging
- President and CEO Tim Moody spoke with Brieanna McCutcheon about the news
- Pan Global Resources Inc. (PGZ) opened trading at $0.345 per share
Pan Global Resources (PGZ) released results from preliminary test work at its La Romana copper-tin-silver discovery in Spain.
Located within its Escacena Project in the Iberian Pyrite Belt, the metallurgical test work was completed by UK-based Wardell Armstrong International.
Two locked cycle flotation tests (LCT) assessed and replicated potential full-scale flotation flow sheet options. LCT1 achieved an 86.4 per cent Cu recovery and copper concentrate grading 28.5 per cent, while LCT2 achieved a higher Cu recovery of 89.5 per cent and a copper concentrate grade of 23.8 per cent.
The metallurgical test work continues, and the company said that the results achieved for the first phase of testing demonstrate the potential for a conventional flotation process flowsheet capable of recovering copper into a saleable concentrate.
Tim Moody, Pan Global President and CEO explained that the favourable combination of low deleterious metals and coarse primary grind size, when compared to what is known of the other deposits in the area, and potential for lower final energy consumption, is highly encouraging.
Moody spoke with Brieanna McCutcheon about the news.
Pan Global Resources Inc. is actively engaged in base and precious metal exploration in southern Spain and is pursuing opportunities from exploration through to mine development.
Pan Global Resources Inc. (PGZ) opened trading at $0.345 per share.
This is sponsored content, please see full disclaimer here.
